Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) Director Keith M. Gehl acquired 403 shares of Kewaunee Scientific stock in a transaction that occurred on Tuesday, March 18th. The stock was acquired at an average price of $49.00 per share, with a total value of $19,747.00. Following the completion of the acquisition, the director now directly owns 17,000 shares in the company, valued at $833,000. This represents a 2.43 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Kewaunee Scientific Price Performance
NASDAQ KEQU opened at $49.69 on Wednesday. Kewaunee Scientific Co. has a one year low of $30.82 and a one year high of $71.33. The stock has a 50-day moving average of $58.16 and a 200 day moving average of $47.77. The company has a market capitalization of $142.71 million, a price-to-earnings ratio of 7.87 and a beta of 0.71. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last released its quarterly earnings results on Wednesday, March 12th. The technology company reported $1.09 EPS for the quarter. The firm had revenue of $67.17 million during the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.
Institutional Trading of Kewaunee Scientific
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in KEQU. Geode Capital Management LLC grew its position in shares of Kewaunee Scientific by 8.9% during the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company's stock valued at $792,000 after acquiring an additional 1,941 shares during the period. JPMorgan Chase & Co. lifted its position in Kewaunee Scientific by 18,000.0% during the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company's stock valued at $30,000 after purchasing an additional 900 shares in the last quarter. Janney Montgomery Scott LLC bought a new stake in Kewaunee Scientific during the fourth quarter valued at about $338,000. Barclays PLC purchased a new stake in Kewaunee Scientific in the third quarter worth about $121,000. Finally, IFP Advisors Inc bought a new position in shares of Kewaunee Scientific in the fourth quarter worth about $36,000. 32.69% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, StockNews.com downgraded Kewaunee Scientific from a "buy" rating to a "hold" rating in a report on Friday, March 14th.
View Our Latest Analysis on Kewaunee Scientific
Kewaunee Scientific Company Profile
(
Get Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
